Canada markets open in 6 hours 10 minutes

Intra-Cellular Therapies, Inc. (ITCI)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
68.80-1.54 (-2.19%)
At close: 04:00PM EDT
69.80 +1.00 (+1.45%)
After hours: 06:16PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 7.26B
Enterprise Value 6.78B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)14.27
Price/Book (mrq)12.28
Enterprise Value/Revenue 14.67
Enterprise Value/EBITDA -42.70

Trading Information

Stock Price History

Beta (5Y Monthly) 1.01
52-Week Change 39.82%
S&P500 52-Week Change 322.38%
52 Week High 384.89
52 Week Low 345.50
50-Day Moving Average 369.24
200-Day Moving Average 362.46

Share Statistics

Avg Vol (3 month) 3983.36k
Avg Vol (10 day) 31.03M
Shares Outstanding 5105.57M
Implied Shares Outstanding 6107.93M
Float 894.76M
% Held by Insiders 12.32%
% Held by Institutions 191.21%
Shares Short (Apr 15, 2024) 43.59M
Short Ratio (Apr 15, 2024) 46.03
Short % of Float (Apr 15, 2024) 44.27%
Short % of Shares Outstanding (Apr 15, 2024) 43.68%
Shares Short (prior month Mar 15, 2024) 43.31M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -30.08%
Operating Margin (ttm)-25.81%

Management Effectiveness

Return on Assets (ttm)-13.43%
Return on Equity (ttm)-22.39%

Income Statement

Revenue (ttm)464.37M
Revenue Per Share (ttm)4.84
Quarterly Revenue Growth (yoy)50.30%
Gross Profit (ttm)N/A
EBITDA -158.85M
Net Income Avi to Common (ttm)-139.67M
Diluted EPS (ttm)-1.46
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)497.94M
Total Cash Per Share (mrq)5.14
Total Debt (mrq)16.94M
Total Debt/Equity (mrq)2.86%
Current Ratio (mrq)5.41
Book Value Per Share (mrq)6.14

Cash Flow Statement

Operating Cash Flow (ttm)-124.2M
Levered Free Cash Flow (ttm)-28.97M